InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Barrett Elizabeth A., 首席执行官. Officer active across 2 companies, notably UroGen Pharma Ltd.. In total, 7 reports have been recorded. Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Barrett Elizabeth A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
3,000 股Common StockSEC:0000950170-25-100675:0
5,000 股Ordinary SharesSEC:0001437749-23-002358:0
5,000 股Ordinary SharesSEC:0001209191-22-006383:0
105,689 股Ordinary SharesSEC:0001209191-22-002305:0
8,807 股Ordinary SharesSEC:0001209191-21-046340:0
8,807 股Ordinary SharesSEC:0001209191-21-046344:0
8,807 股Ordinary SharesSEC:0001209191-21-034823:0
7 条申报中的 7 条
About Barrett Elizabeth A.
Barrett Elizabeth A. is the Chief Executive Officer of UroGen Pharma Ltd. She leads the company with a strategic vision focused on innovation and the development of treatments for urological diseases. Elizabeth plays a crucial role in defining the company's objectives and overseeing its operations to ensure growth and success.
